PATH vs RPID
Uipath Inc (PATH) versus Rapid Micro Biosystems Inc (RPID) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Rapid Micro Biosystems Inc (RPID) is a medical devices company listed on NASDAQ.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported RPID revenue for 2024-12-31 was $28.1M. Net income was -$46.9M. Revenue was up 24.6% from 2023-12-31 to 2024-12-31. RPID currently screens at market cap $85.7M.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. RPID currently screens at market cap $85.7M.
Not investment advice. Open the PATH and RPID stock pages for the full models.
Not investment advice.